Franco M. Locatelli
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 928 publications
HLA-Haploidentical Anti-CD7 Chimeric Antigen Receptor (CAR) T Cells for Transplant-Naïve Patients With Refractory T-Cell Acute Lymphoblastic Leukemia.
Journal: American journal of hematology
Published: July 08, 2026
Clinical features and management of LICATS involving the heart in a patient with diffuse and rapidly progressive systemic sclerosis.
Journal: EULAR rheumatology open
Published: June 29, 2026
2026 Update on Clinical Trials in β-Thalassemia.
Journal: American journal of hematology
Published: June 11, 2026
Exa-cel in Children with Transfusion-Dependent β-Thalassemia or Sickle Cell Disease.
Journal: The New England journal of medicine
Published: June 11, 2026
Efficacy of blinatumomab for dermatomyositis/SLE overlap syndrome occurring after allogeneic hematopoietic stem cell transplant performed for acute lymphoblastic leukemia.
Journal: Bone marrow transplantation
Published: June 01, 2026
Immunoglobulin Depletion and Recovery Following Blinatumomab in Infants With KMT2A-Rearranged ALL.
Journal: Pediatric blood & cancer
Published: June 01, 2026
Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children and Young Adults with Ewing Sarcoma.
Journal: Transplantation and cellular therapy
Published: May 26, 2026
Dinutuximab beta with TEMIRI chemotherapy in relapsed/refractory neuroblastoma: Real-world insights into the open question of GD2 expression.
Journal: Translational oncology
Published: May 18, 2026
Correction of Ineffective Erythropoiesis and Normalization of Iron Homeostasis After Exagamglogene Autotemcel in Transfusion-Dependent β-Thalassemia.
Journal: American journal of hematology
Published: May 14, 2026
Overcoming disease refractoriness through CD7-targeting CAR T cells in acute myeloid leukemia.
Journal: Molecular therapy. Oncology
Published: May 08, 2026
Sinusoidal obstruction syndrome in children with B-acute lymphoblastic leukemia (B-ALL) treated with inotuzumab ozogamicin: Results from the ITCC-059 trial.
Journal: HemaSphere
Published: May 06, 2026
CAR-T cell therapy: "New black" for children with severe, refractory, B cell-mediated autoimmune disorders.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 08, 2026
Last Updated: 09/26/2026